Icahn School of Medicine at Mount Sinai

Overview

Description for Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai (ISMMS) is a private medical school located in New York City, New York. In 1963, Mount Sinai Hospital chartered the school to be its main teaching hospital. In 1982, it was the first medical school to create a geriatrics department in the U.S. With a $2.9 billion annual budget, it currently ranks among the top 20 research-based medical schools worldwide and is an acknowledged leader in biomedical health sciences.

Icahn School of Medicine at Mount Sinai Key Statistics

ISMMS comprises 34 academic units, which include the Department of Obstetrics, Gynecology, and Reproductive Science, the Department of Cell, Developmental and Regenerative Biology, the Department of Diagnostic, Molecular and Interventional Radiology, and the Department of Diagnostic, Molecular and Interventional Radiology

It has a total of 1,233 students, which include 582 postdoctoral fellows, 329 master's students, 311 Ph.D. students, 92 M.D./Ph.D. students, and 578 medical students. The medical school also has over 2,000 fellows and residents.

The other Icahn School of Medicine at Mount Sinai key statistics include its more than 6,500 full-time, part-time, and voluntary teaching personnel and the 5,640 full-time administrative staff.

Icahn School of Medicine at Mount Sinai Research

ISMMS is composed of 39 multidisciplinary research centers and clinical Institutes. Propelled by its groundbreaking research projects, the medical school has received a total of $413 million in funding awarded by the National Institutes of Health for 2020.

The top three fields of research of Icahn School of Medicine at Mount Sinai are medicine, biology, and internal medicine. Its researchers have published in prestigious journals including The Lancet, The Journal of Allergy and Clinical Immunology, and the American Journal of Human Genetics. Many of them have also attended and/or been invited to present their research at international scholarly and professional conferences such as the International Conference on Management of Data, Web Science, and Principles and Practice of Constraint Programming.

The most cited publication by Icahn School of Medicine at Mount Sinai research is Gentleman et al.’s (2004) “Bioconductor: open software development for computational biology and bioinformatics,” which was published in Genome Biology and has generated a total of 12,595 citations to date. The university’s second most cited work is Llovet et al.’s (2008) “Sorafenib in advanced hepatocellular carcinoma.” Published in The New England Journal of Medicine, this article has received 12,313 citations. In addition, the third most cited ISMMS research output is Polman et al.’s (2011) “Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria,” featured in the Annals of Neurology and was cited 8,765 times.

Some of Icahn School of Medicine at Mount Sinai research centers include the Brain Injury Research Center of Mount Sinai, the Center for Bariatric and Minimally Invasive Surgery, the Center for Interventional Cardiovascular Research and Clinical Trials, and The Barbara and Maurice Deane Prostate Health and Research Center.

Moreover, it has numerous clinical laboratories like the Anne Bowcock Laboratory that investigates the human genes’ spontaneous modifications or genetic differences that result in diseases. It also aims to understand the genetic foundations of cancer and diseases.